Regulation of immune responses to protein therapeutics by transplacental induction of T cell tolerance

Science Translational Medicine

Volumn 7, Issue 275, 2015, Pages

  Gupta, Nimesh ^a,b,c   Culina, Slobodan ^d,e,f   Meslier, Yann ^a,b,c   Dimitrov, Jordan ^a,b,c   Arnoult, Christophe ^g   Delignat, Sandrine ^a,b,c   Gangadharan, Bagirath ^a,b,c   Lecerf, Maxime ^a,b,c   Justesen, Sune ^h   Gouilleux Gruart, Valérie ^g,i   Salomon, Benoit L ^a,c   Scott, David W ^j   Kaveri, Srinivas V ^a,b,c   Mallone, Roberto ^d,e,f,k   Lacroix Desmazes, Sébastien ^a,b,c  

^a INSERM   (France)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d INSTITUT COCHIN   (France)

^e CNRS   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g UNIVERSITÉ DE TOURS   (France)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

ⁱ UNIVERSITY HOSPITAL OF TOURS   (France)

^j UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^k Uniformed Services University of the Health Sciences ^*  (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; FC RECEPTOR; HEMAGGLUTININ; HEMAGGLUTININ 1; IMMUNOGLOBULIN G; NEONATAL FC RECEPTOR; UNCLASSIFIED DRUG; F8 PROTEIN, HUMAN; NEUTRALIZING ANTIBODY;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW CELL; ENDOCYTOSIS; FEMALE; FETUS; HEMOPHILIA A; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOID ORGAN; MOUSE; NONHUMAN; PLACENTAL TRANSFER; REGULATORY T LYMPHOCYTE; TRANSPLACENTAL DRUG ADMINISTRATION; ANIMAL; FETOMATERNAL TRANSFUSION; IMMUNOLOGY; PLACENTA; PREGNANCY; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIGEN-PRESENTING CELLS; ENDOCYTOSIS; FACTOR VIII; FEMALE; HEMOPHILIA A; IMMUNE TOLERANCE; MATERNAL-FETAL EXCHANGE; MICE; PLACENTA; PREGNANCY; T-LYMPHOCYTES;

EID: 84923107017     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaa1957     Document Type: Article

References (65)

1. S. Dasgupta, J. Bayry, S. André, J. D. Dimitrov, S. V. Kaveri, S. Lacroix-Desmazes, Auditing protein therapeutics management by professional APCs: Toward prevention of immune responses against therapeutic proteins. J. Immunol. 181, 1609-1615 (2008).
2. S. D. Miller, D. M. Turley, J. R. Podojil, Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat. Rev. Immunol. 7, 665-677 (2007).
3. K. E. Webster, S. Walters, R. E. Kohler, T. Mrkvan, O. Boyman, C. D. Surh, S. T. Grey, J. Sprent, In vivo expansion of T reg cells with IL-2-mAb complexes: Induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J. Exp. Med. 206, 751-760 (2009).
4. reg vaccination in vivo. Proc. Natl. Acad. Sci. U. S. A. 107, 16246-16251 (2010).
5. S. Sauer, L. Bruno, A. Hertweck, D. Finlay, M. Leleu, M. Spivakov, Z. A. Knight, B. S. Cobb, D. Cantrell, E. O 'Connor, K. M. Shokat, A. G. Fisher, M. Merkenschlager, T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. U.S.A. 105, 7797-7802 (2008).
6. 1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat. Immunol. 10, 769-777 (2009).
7. G. Marodon, S. Fisson, B. Levacher, M. Fabre, B. L. Salomon, D. Klatzmann, Induction of antigen-specific tolerance by intrathymic injection of lentiviral vectors. Blood 108, 2972-2978 (2006).
8. M. S. Jordan, A. Boesteanu, A. J. Reed, A. L. Petrone, A. E. Holenbeck, M. A. Lerman, A. Naji, A. J. Caton, Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2, 301-306 (2001).
9. I. Apostolou, A. Sarukhan, L. Klein, H. von Boehmer, Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3, 756-763 (2002).
10. M. Guerau-de-Arellano, M. Martinic, C. Benoist, D. Mathis, Neonatal tolerance revisited: A perinatal window for Aire control of autoimmunity. J. Exp. Med. 206, 1245-1252 (2009).
11. R. E. Billingham, L. Brent, P. B. Medawar, Actively acquired tolerance of foreign cells. Nature 172, 603-606 (1953).
12. J. E. Mold, J. Michaëlsson, T. D. Burt, M. O. Muench, K. P. Beckerman, M. P. Busch, T. H. Lee, D. F. Nixon, J. M. McCune, Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 322, 1562-1565 (2008).
13. S. Ehrenforth, W. Kreuz, I. Scharrer, R. Linde, M. Funk, T. Güngör, B. Krackhardt, B. Kornhuber, Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet 339, 594-598 (1992).
14. D. C. Roopenian, S. Akilesh, FcRn: The neonatal Fc receptor comes of age. Nat. Rev. Immunol. 7, 715-725 (2007).
15. T. Suzuki, A. Ishii-Watabe, M. Tada, T. Kobayashi, T. Kanayasu-Toyoda, T. Kawanishi, T. Yamaguchi, Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: A comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR. J. Immunol. 184, 1968-1976 (2010).
16. H. Zaghouani, R. Steinman, R. Nonacs, H. Shah, W. Gerhard, C. Bona, Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule. Science 259, 224-227 (1993).
17. K. S. Landreth, Critical windows in development of the rodent immune system. Hum. Exp. Toxicol. 21, 493-498 (2002).
18. H. R. Snodgrass, P. Kisielow, M. Kiefer, M. Steinmetz, H. von Boehmer, Ontogeny of the T-cell antigen receptor within the thymus. Nature 313, 592-595 (1985).
19. J. F. Miller, The golden anniversary of the thymus. Nat. Rev. Immunol. 11, 489-495 (2011).
20. J. D. Fontenot, J. L. Dooley, A. G. Farr, A. Y. Rudensky, Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 202, 901-906 (2005).
21. S. P. Berzins, R. L. Boyd, J. F. Miller, The role of the thymus and recent thymic migrants in the maintenance of the adult peripheral lymphocyte pool. J. Exp. Med. 187, 1839-1848 (1998).
22. M. Asano, M. Toda, N. Sakaguchi, S. Sakaguchi, Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184, 387-396 (1996).
23. L. Klein, M. Hinterberger, G. Wirnsberger, B. Kyewski, Antigen presentation in the thymus for positive selection and central tolerance induction. Nat. Rev. Immunol. 9, 833-844 (2009).
24. L. A. Pobezinsky, G. S. Angelov, X. Tai, S. Jeurling, F. Van Laethem, L. Feigenbaum, J. H. Park, A. Singer, Clonal deletion and the fate of autoreactive thymocytes that survive negative selection. Nat. Immunol. 13, 569-578 (2012).
25. D. Naeher, M. A. Daniels, B. Hausmann, P. Guillaume, I. Luescher, E. Palmer, A constant affinity threshold for T cell tolerance. J. Exp. Med. 204, 2553-2559 (2007).
26. J. Kirberg, A. Baron, S. Jakob, A. Rolink, K. Karjalainen, H. von Boehmer, Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor. J. Exp. Med. 180, 25-34 (1994).
27. H. von Boehmer, P. Kisielow, Self-nonself discrimination by T cells. Science 248, 1369-1373 (1990).
28. M. A. Curotto de Lafaille, J. J. Lafaille, Natural and adaptive foxp3+ regulatory T cells: More of the same or a division of labor? Immunity 30, 626-635 (2009).
29. M. Yadav, C. Louvet, D. Davini, J. M. Gardner, M. Martinez-Llordella, S. Bailey-Bucktrout, B. A. Anthony, F. M. Sverdrup, R. Head, D. J. Kuster, P. Ruminski, D. Weiss, D. Von Schack, J. A. Bluestone, Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J. Exp. Med. 209, 1713-1722 (2012).
30. J. M. Weiss, A. M. Bilate, M. Gobert, Y. Ding, M. A. Curotto de Lafaille, C. N. Parkhurst, H. Xiong, J. Dolpady, A. B. Frey, M. G. Ruocco, Y. Yang, S. Floess, J. Huehn, S. Oh, M. O. Li, R. E. Niec, A. Y. Rudensky, M. L. Dustin, D. R. Littman, J. J. Lafaille, Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J. Exp. Med. 209, 1723-1742 (2012).
31. I. Apostolou, H. von Boehmer, In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199, 1401-1408 (2004).
32. K. Kretschmer, I. Apostolou, D. Hawiger, K. Khazaie, M. C. Nussenzweig, H. von Boehmer, Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6, 1219-1227 (2005).
33. D. Haribhai, J. B. Williams, S. Jia, D. Nickerson, E. G. Schmitt, B. Edwards, J. Ziegelbauer, M. Yassai, S. H. Li, L. M. Relland, P. M. Wise, A. Chen, Y. Q. Zheng, P. M. Simpson, J. Gorski, N. H. Salzman, M. J. Hessner, T. A. Chatila, C. B. Williams, A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity 35, 109-122 (2011).
34. R. A. Gottschalk, E. Corse, J. P. Allison, TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J. Exp. Med. 207, 1701-1711 (2010).
35. P. Yu, C. L. Haymaker, R. D. Divekar, J. S. Ellis, J. Hardaway, R. Jain, D. M. Tartar, C. M. Hoeman, J. A. Cascio, A. Ostermeier, H. Zaghouani, Fetal exposure to high-avidity TCR ligand enhances expansion of peripheral T regulatory cells. J. Immunol. 181, 73-80 (2008).
36. M. Miyara, S. Sakaguchi, Natural regulatory T cells: Mechanisms of suppression. Trends Mol. Med. 13, 108-116 (2007).
37. S. Z. Josefowicz, L. F. Lu, A. Y. Rudensky, Regulatory T cells: Mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531-564 (2012).
38. E. M. Shevach, Mechanisms of Foxp3+ T regulatory cell-mediated suppression. Immunity 30, 636-645 (2009).
39. + conventional dendritic cells in presentation of blood-derived lysozyme by MHC class II proteins. J. Immunol. 186, 1421-1431 (2011).
40. + conventional dendritic cells to central tolerance against blood-borne antigens in a CCR2-dependent manner. J. Immunol. 183, 3053-3063 (2009).
41. A. I. Proietto, S. van Dommelen, P. Zhou, A. Rizzitelli, A. D'Amico, R. J. Steptoe, S. H. Naik, M. H. Lahoud, Y. Liu, P. Zheng, K. Shortman, L. Wu, Dendritic cells in the thymus contribute to T-regulatory cell induction. Proc. Natl. Acad. Sci. U.S.A. 105, 19869-19874 (2008).
42. H. Wu, M. Reding, J. Qian, D. K. Okita, E. Parker, P. Lollar, L. W. Hoyer, B. M. Conti-Fine, Mechanism of the immune response to human factor VIII in murine hemophilia A. Thromb. Haemost. 85, 125-133 (2001).
43. L. Bi, A. M. Lawler, S. E. Antonarakis, K. A. High, J. D. Gearhart, H. H. Kazazian Jr., Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat. Genet. 10, 119-121 (1995).
44. J. F. Healey, E. T. Parker, R. T. Barrow, T. J. Langley, W. R. Church, P. Lollar, The humoral response to human factor VIII in hemophilia A mice. J. Thromb. Haemost. 5, 512-519 (2007).
45. T. C. Lei, D. W. Scott, Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins. Blood 105, 4865-4870 (2005).
46. B. Moghimi, B. K. Sack, S. Nayak, D. M. Markusic, C. S. Mah, R. W. Herzog, Induction of tolerance to factor VIII by transient co-administration with rapamycin. J. Thromb. Haemost. 9, 1524-1533 (2011).
47. A. Sherman, J. Su, S. Lin, X. Wang, R. W. Herzog, H. Daniell, Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells. Blood 124, 1659-1668 (2014).
48. J. Skupsky, A. H. Zhang, Y. Su, D. W. Scott, B-cell-delivered gene therapy induces functional T regulatory cells and leads to a loss of antigen-specific effector cells. Mol. Ther. 18, 1527-1535 (2010).
49. + regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia mice. Blood 114, 4034-4044 (2009).
50. F. Saji, Y. Samejima, S. Kamiura, M. Koyama, Dynamics of immunoglobulins at the fetomaternal interface. Rev. Reprod. 4, 81-89 (1999).
51. A. Malek, R. Sager, P. Kuhn, K. H. Nicolaides, H. Schneider, Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am. J. Reprod. Immunol. 36, 248-255 (1996).
52. + regulatory/suppressor T cells in human fetuses. Blood 105, 4715-4721 (2005).
53. S. D. Holladay, R. J. Smialowicz, Development of the murine and human immune system: Differential effects of immunotoxicants depend on time of exposure. Environ. Health Perspect. 108 (Suppl. 3), 463-473 (2000).
54. D. M. DiMichele, Inhibitors in childhood hemophilia A: Genetic and treatment-related risk factors for development and eradication. Pediatr. Blood Cancer 60 (Suppl. 1), S30-S33 (2013).
55. F. Peyvandi, Carrier detection and prenatal diagnosis of hemophilia in developing countries. Semin. Thromb. Hemost. 31, 544-554 (2005).
56. S. C. Gouw, H. M. van den Berg, K. Fischer, G. Auerswald, M. Carcao, E. Chalmers, H. Chambost, K. Kurnik, R. Liesner, P. Petrini, H. Platokouki, C. Altisent, J. Oldenburg, B. Nolan, R. P. Garrido, M. E. Mancuso, A. Rafowicz, M. Williams, N. Clausen, R. A. Middelburg, R. Ljung, J. G. van der Bom; PedNet and Research of Determinants of INhibitor development (RODIN) Study Group, Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: The RODIN study. Blood 121, 4046-4055 (2013).
57. S. C. Gouw, J. G. van der Bom, H. Marijke van den Berg, Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: The CANAL cohort study. Blood 109, 4648-4654 (2007).
58. J. M. Chiller, W. O. Weigle, Cellular events during induction of immunologic unresponsiveness in adult mice. J. Immunol. 106, 1647-1653 (1971).
59. Y. P. Rubtsov, R. E. Niec, S. Josefowicz, L. Li, J. Darce, D. Mathis, C. Benoist, A. Y. Rudensky, Stability of the regulatory T cell lineage in vivo. Science 329, 1667-1671 (2010).
60. + T cells in the periphery. Nat. Rev. Immunol. 7, 231-237 (2007).
61. S. Sakaguchi, D. A. Vignali, A. Y. Rudensky, R. E. Niec, H. Waldmann, The plasticity and stability of regulatory T cells. Nat. Rev. Immunol. 13, 461-467 (2013).
62. J. Mahlangu, J. S. Powell, M. V. Ragni, P. Chowdary, N. C. Josephson, I. Pabinger, H. Hanabusa, N. Gupta, R. Kulkarni, P. Fogarty, D. Perry, A. Shapiro, K. J. Pasi, S. Apte, I. Nestorov, H. Jiang, S. Li, S. Neelakantan, L. M. Cristiano, J. Goyal, J. M. Sommer, J. A. Dumont, N. Dodd, K. Nugent, G. Vigliani, A. Luk, A. Brennan, G. F. Pierce; A-LONG Investigators, Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A. Blood 123, 317-325 (2014).
63. P. M. Mannucci, E. G. Tuddenham, The hemophilias - From royal genes to gene therapy. N. Engl. J. Med. 344, 1773-1779 (2001).
64. J. S. Powell, K. J. Pasi, M. V. Ragni, M. C. Ozelo, L. A. Valentino, J. N. Mahlangu, N. C. Josephson, D. Perry, M. J. Manco-Johnson, S. Apte, R. I. Baker, G. C. Chan, N. Novitzky, R. S. Wong, S. Krassova, G. Allen, H. Jiang, A. Innes, S. Li, L. M. Cristiano, J. Goyal, J. M. Sommer, J. A. Dumont, K. Nugent, G. Vigliani, A. Brennan, A. Luk, G. F. Pierce; B-LONG Investigators, Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B. N. Engl. J. Med. 369, 2313-2323 (2013).
65. N. J. Mendelsohn, Y. H. Messinger, A. S. Rosenberg, P. S. Kishnani, Elimination of antibodies to recombinant enzyme in Pompe's disease. N. Engl. J. Med. 360, 194-195 (2009).